dimethoxyphenylethylamine has been researched along with Encephalopathy, Toxic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angerer, V; Auwärter, V; Grumann, C; Hermanns-Clausen, M; Kithinji, J | 1 |
Hegarty, CB; Janis, GC; Kealey, SE; Stellpflug, SJ | 1 |
2 other study(ies) available for dimethoxyphenylethylamine and Encephalopathy, Toxic
Article | Year |
---|---|
Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus.
Topics: Accidents; Adult; Analgesics; Chromatography, Liquid; Dimethoxyphenylethylamine; Humans; Male; Neurotoxicity Syndromes; Poisoning; Serotonin 5-HT2 Receptor Agonists; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2017 |
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
Topics: Adolescent; Benzylamines; Biomarkers; Biotransformation; Designer Drugs; Dimethoxyphenylethylamine; Epilepsy, Tonic-Clonic; Female; Hallucinogens; Humans; Minnesota; Neurotoxicity Syndromes; Phenethylamines; Substance Abuse Detection; Treatment Outcome | 2014 |